Item


An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies

A new anticancer agent based on the conjugation of a photoactivatable Pt(iv) pro-drug to a cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was induced preferentially in SK-MEL-28 melanoma cancer cells overexpressing αVβ3 integrin compared to control DU-145 human prostate carcinoma cells

Royal Society of Chemistry (RSC)

Author: Gandioso, Albert
Shaili, Evyenia
Massaguer i Vall-llovera, Anna
Artigas, Gerard
González-Cantó, Alejandro
Woods, Julie A.
Sadler, Evyenia
Marchán, Vicente
Date: 2018 June 5
Abstract: A new anticancer agent based on the conjugation of a photoactivatable Pt(iv) pro-drug to a cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was induced preferentially in SK-MEL-28 melanoma cancer cells overexpressing αVβ3 integrin compared to control DU-145 human prostate carcinoma cells
Document access: http://hdl.handle.net/2072/320976
Language: eng
Publisher: Royal Society of Chemistry (RSC)
Rights: Attribution 3.0 Spain
Rights URI: http://creativecommons.org/licenses/by/3.0/es/
Subject: Medicaments antineoplàstics
Antineoplastic agents
Title: An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies
Type: info:eu-repo/semantics/article
Repository: Recercat

Subjects

Authors